Post-approval studies (Phase 4)Looking for participantsNCT06186037
What this trial is testing
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Who this might be right for
Coronary Artery DiseaseDyslipidemiasPrimary Prevention
Saint Vincent's Hospital, Korea 6,356